OPIANT PHARMACEUTICALS, INC. Development Agreements
4 Contracts & Agreements
- Contract between the Company and Biomedical Advanced Research and Development Authority dated September 19, 2018 (Filed With SEC on December 4, 2018)
- Contract between the Company and Biomedical Advanced Research and Development Authority dated September 19, 2018 (Filed With SEC on September 20, 2018)
- Development and Manufacturing Agreement between the Company and Aesica Queensborough Limited dated September 7, 2018 (Filed With SEC on September 10, 2018)
- Research and Development Agreement, dated as of July 14, 2017, by and between the Company and Renaissance Lakewood, LLC (Filed With SEC on October 13, 2017)
